Status:
COMPLETED
Clinical Implementation of Carrier Status Using Next Generation Sequencing
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Human Genome Research Institute (NHGRI)
Conditions:
Genetic Disorders
Eligibility:
All Genders
21-50 years
Phase:
NA
Brief Summary
This study is conducting a randomized controlled trial (RCT) with up to 400 subjects (women \& partners) seeking pre-conception carrier testing to assess the impact of the program using Whole Genome S...
Detailed Description
Project 1-Clinical Intervention and Outcomes Aim 1: To conduct a randomized controlled trial (RCT) with up to 400 subjects (women \& partners) seeking pre-conception carrier testing to assess the impa...
Eligibility Criteria
Inclusion
- Seeking pre-conception carrier status testing or had carrier testing during pregnancy
- Women with a male partner that can be contacted
- Kaiser Permanente Northwest members
- English speaking
- Not currently pregnant
Exclusion
- Currently pregnant
- No known or accessible male partner
- Not an English speaker
- Not a Kaiser Permanente member
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT01902901
Start Date
January 1 2014
End Date
May 1 2018
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northwest
Portland, Oregon, United States, 97227